You probably love to play games. These games were made just for you. They’re really fun, and you can learn something about CF, too.
The lungs are on high alert – mucus is invading! Get to the battle station and cut them down to size with the scissor-flinger and powerful back-claps.
Discover all the fun you can have by mixing up your tasty treats! The Food Flip-Flop is a race against time.
Deoxyribo-what!? Think you know all those long words related to cystic fibrosis? Put your smarts to the test with our Pulmozyme Word Scramble.
Indication and Usage
Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics. In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.
Important Safety Information
Pulmozyme should not be used in patients who are allergic to any of its
Pulmozyme should be used along with standard therapies for cystic fibrosis
When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose
These side effects are usually mild and short-lived
The effect of Pulmozyme on exercise tolerance has not been established in adults and children
For further information, please see the Pulmozyme full prescribing information. If you have questions, please discuss them with your CF healthcare team.